Effects of dietary iron reduction versus phlebotomy in patients with chronic hepatitis C: Results from a randomized, controlled trial on 40 Japanese patients

Internal Medicine

Volumn 46, Issue 10, 2007, Pages 637-642

  Sumida, Yoshio ^a   Kanemasa, Kazuyuki ^a   Fukumoto, Kohei ^a   Yoshida, Naohisa ^a   Sakai, Kyoto ^a  

^a Nara City Hospital   (Japan)

Author keywords

Chronic hepatitis C; Diet; Iron; Oxidative stress; Phlebotomy

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN; GLYCYRRHIZIC ACID; INTERFERON; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FERRITIN BLOOD LEVEL; HEART PALPITATION; HEMOGLOBIN DETERMINATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON RESTRICTION; LABORATORY TEST; MALE; MONOTHERAPY; PHLEBOTOMY; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT; TRANSITIONAL BLINDNESS;

ADULT; AGED; ALANINE TRANSAMINASE; FEMALE; FERRITINS; HEPATITIS C, CHRONIC; HUMANS; IRON; IRON OVERLOAD; IRON, DIETARY; MALE; MIDDLE AGED; PHLEBOTOMY; TREATMENT OUTCOME;

EID: 34249825477     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6085     Document Type: Article

References (23)

1. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 25: 759-768, 1997.
2. Farinati F, Cardin R, De Maria N, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22: 449-456, 1995.
3. Sumida Y, Nakashima T, Yoh T, et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 33: 616-622, 2000.
4. Hayashi H, Takikawa T, Nishimura N, et al. Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C. J Hepatol 22: 268-271, 1995.
5. Hayashi H, Takikawa T, Nishimura N, et al. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 89: 986-988, 1994.
6. Piperno A, Sampietro M, D'Alba Ro M, et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C, Liver 16: 248-254, 1996.
7. Kato N, Yokosuka O, Omata M, et al. Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. J Clin Invest 86: 1764-1767, 1990.
8. Karen Y, Jennifer A, Yokosuka O, et al. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: Comparison with nested amplication and antibody testing. J Clin Microbiol 33: 654-657, 1995.
9. Tanaka T, Tsukiyama-Kohara K, Yamaguti K, et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 19: 1347-1353, 1994.
10. Yano M, Hayashi H, Wakusawa S, et al. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C. Am J Gastroenterol 97: 133-137, 2002.
11. Leonardi S, Musumeci S. Could chelation therapy with deferoxamine enhance the percentage of responders to interferon therapy in chronic hepatitis C? Acta Haematol 90: 211-212, 1993.
12. Weinberg K. Novel use of deferoxamine. Am J Pediatr Hematol Oncol 12: 9-13, 1990.
13. Bassett SE, Di Bisceglie AM, Bacon BR, et al. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees. Hepatology 29: 1884-1892, 1999.
14. Tandon N, Thakur V, Guptan RC, et al. Beneficial influence of an indigenous low-iron diet on serum indicators of iron status in patients with chronic liver disease. Br J Nutr 83: 235-239, 2000.
15. Turnbull A, Cleton F, Finch CA. Iron absorption. IV. The absorption of hemoglobin iron. J Clin Invest 41: 1897-1907, 1962.
16. Björn-Rasmussen E, Hallberg L, Isaksson B, et al. Food iron absorption in man. J Clin Invest 53: 247-255, 1974.
17. Kelly KA, Turnbull A, Cammock EE, et al. Iron absorption after gastrectomy: An experimental study in the dog. Surgery 62: 356-360, 1967.
18. Thomas HB, Robert WC, James DC, et al. Iron absorption, IN metabolism in man. Blackwell Scientific Publications, Oxford, 256-283, 1979.
19. Hayashi H, Takikawa T, Arai N, et al. The advantage of gastrectomized patients in management of their chronic hepatitis C. Nagoya J Med Sci 60: 119-127, 1997.
20. Cook JD, Layrisse M, Martinez-Torres C, et al. Food iron absorption measured by an extrinsic tag. J Clin Invest 51: 805-815, 1972.
21. Duane P, Raja KB, Simpson RJ, Peters TJ. Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol 27: 539-544, 1992.
22. Disler PB, Lynch SR, Charlton RW, et al. The effect of tea on iron absorption. Gut 16: 193-200, 1975.
23. De Alarcon PA, Donovan ME, Forbes GB, et al. Iron absorption in the thalassemia syndromes and its inhibition by tea. N Engl J Med 300: 5-8, 1979.